Literature DB >> 24686358

Can percutaneous cholecystostomy be a definitive management for acute cholecystitis in high-risk patients?

Enver Zerem1, Safet Omerović.   

Abstract

PURPOSE: To evaluate the efficacy, long-term outcome, and safety of percutaneous cholecystostomy (PC) in high-risk surgical patients.
METHODS: This was a retrospective descriptive review of the medical records of 36 patients who underwent PC for acute cholecystitis (AC) at a single institution between 2000 and 2011. Primary outcomes were overall morbidity, mortality, and need for interval cholecystectomy.
RESULTS: PC was initially successful, and symptoms disappeared within 3 days in all patients. Seven patients (2 during hospitalization and 5 during follow-up) died, 6 for a reason unrelated to AC, and 1 succumbed to a sepsis-related condition caused by uncontrolled cholecystitis progression. Elective cholecystectomy was performed in 6 patients. PC was a definitive treatment in 63.9% of patients.
CONCLUSIONS: PC is a safe and efficient treatment option for patients with AC who are less eligible for surgery. After patients recover from PC, further treatment such as cholecystectomy may not be needed.

Entities:  

Mesh:

Year:  2014        PMID: 24686358     DOI: 10.1097/SLE.0b013e31828fa45e

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  8 in total

1.  Percutaneous Cholecystostomy Versus Conservative Treatment for Acute Cholecystitis: a Cohort Study.

Authors:  Stine Ydegaard Turiño; Daniel Mønsted Shabanzadeh; Nethe Malik Eichen; Stine Lundgaard Jørgensen; Lars Tue Sørensen; Lars Nannestad Jørgensen
Journal:  J Gastrointest Surg       Date:  2018-11-02       Impact factor: 3.452

2.  Early laparoscopic cholecystectomy in oldest-old patients: a propensity score matched analysis of a nationwide registry.

Authors:  Marcello Di Martino; Álvaro Gancedo Quintana; Víctor Vaello Jodra; Alfonso Sanjuanbenito Dehesa; Dieter Morales García; Rubén Caiña Ruiz; Francisca García-Moreno Nisa; Fernando Mendoza-Moreno; Sara Alonso Batanero; José Edecio Quiñones Sampedro; Paola Lora Cumplido; Altea Arango Bravo; Ines Rubio-Perez; Luis Asensio-Gomez; Fernando Pardo Aranda; Sara Sentí Farrarons; Cristina Ruiz Moreno; Clara Maria Martinez Moreno; Aingeru Sarriugarte Lasarte; Mikel Prieto Calvo; Daniel Aparicio-Sánchez; Eduardo Perea Perea Del Pozo; Gianluca Pellino; Elena Martin-Perez
Journal:  Updates Surg       Date:  2022-03-06

3.  Percutaneous cholecystostomy… why, when, what next? A systematic review of past decade.

Authors:  M Elsharif; A Forouzanfar; K Oaikhinan; Niraj Khetan
Journal:  Ann R Coll Surg Engl       Date:  2018-10-05       Impact factor: 1.891

4.  Early Percutaneous Cholecystostomy in Severe Acute Cholecystitis Reduces the Complication Rate and Duration of Hospital Stay.

Authors:  Chung-Kai Chou; Kuei-Chuan Lee; Che-Chang Chan; Chin-Lin Perng; Chun-Ku Chen; Wen-Liang Fang; Han-Chieh Lin
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  Percutaneous cholecystostomy for delayed laparoscopic cholecystectomy in patients with acute cholecystitis: analysis of a single-centre experience and literature review.

Authors:  Erdinc Kamer; Fevzi Cengiz; Volkan Cakir; Omur Balli; Turan Acar; Mustafa Peskersoy; Mehmet Haciyanli
Journal:  Prz Gastroenterol       Date:  2017-12-14

6.  Safety and Efficacy of Percutaneous Cholecystostomy for Emphysematous Cholecystitis.

Authors:  Amir Imanzadeh; Nima Kokabi; Sarvenaz Pourjabbar; Igor Latich; Jeffrey Pollak; Hyun Kim; Gowthaman Gunabushanam
Journal:  J Clin Imaging Sci       Date:  2020-03-27

7.  Percutaneous biliary drainage for obstructive jaundice in patients with inoperable, malignant biliary obstruction.

Authors:  Enver Zerem; Bilal Imširović; Suad Kunosić; Dina Zerem; Omar Zerem
Journal:  Clin Exp Hepatol       Date:  2022-03-23

8.  Long-Term Outcomes of Patients with Acute Cholecystitis after Successful Percutaneous Cholecystostomy Treatment and the Risk Factors for Recurrence: A Decade Experience at a Single Center.

Authors:  Chih-Hung Wang; Cheng-Yi Wu; Justin Cheng-Ta Yang; Wan-Ching Lien; Hsiu-Po Wang; Kao-Lang Liu; Yao-Ming Wu; Shyr-Chyr Chen
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.